Stefano Ferraresi
Partner, Private Equity, Head of Industrials, Member of the Management Committee
IGS GeboJagema
In August 2025, BC Partners acquired IGS GeboJagema. Founded in 1945 and headquartered in Eindhoven, the Netherlands, IGS GeboJagema is the global leading, pure-play healthcare, high-precision mould technology provider.
IGS designs and manufactures complex, high-precision moulds used in the production of critical medical devices, including drug delivery systems, contact lenses, diagnostic equipment and healthcare consumables. With decades of specialised expertise and delivering to exacting standards, IGS has built a strong reputation as a global leader, in the supply of mission-critical tooling to the world’s leading healthcare and pharmaceutical companies.
- Sector
- Healthcare
- Strategy
- Private Equity
- Investment year
- 2025
- Region
- Europe
- Investment status
- Unrealised
Team involved
Matthew Evans
Managing Director, Private Equity
Blanca Ruiz Prada
Director, Private Equity
Ed Stanley
Associate, Private Equity
Daniel Fuchs
Principal, Private Equity
Adi Venkatraman
Associate, Private Equity
Company news
Press Release
BC Partners to invest in IGS GeboJagema in partnership with management and Smile Invest
IGS GeboJagema (“IGS”) (www.igsgebojagema.nl), the leading independent healthcare manufacturer in the tooling market for medical devices, announces, together with its…
Our partnerships
At BC, we provide our portfolio companies with the access and expertise to scale into leading global businesses. We are a partner for growth.